These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10944612)

  • 1. Influence of tumour size on uptake of(111)ln-DTPA-labelled pegylated liposomes in a human tumour xenograft model.
    Harrington KJ; Rowlinson-Busza G; Syrigos KN; Abra RM; Uster PS; Peters AM; Stewart JS
    Br J Cancer; 2000 Sep; 83(5):684-8. PubMed ID: 10944612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies.
    Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Abra RM; Stewart JS
    Br J Cancer; 2000 Jul; 83(2):232-8. PubMed ID: 10901376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery.
    Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Vile RG; Stewart JS
    Clin Cancer Res; 2000 Jun; 6(6):2528-37. PubMed ID: 10873109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model.
    Harrington KJ; Rowlinson-Busza G; Syrigos KN; Vile RG; Uster PS; Peters AM; Stewart JS
    Clin Cancer Res; 2000 Dec; 6(12):4939-49. PubMed ID: 11156255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
    J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-fraction irradiation has no effect on uptake of radiolabeled pegylated liposomes in a tumor xenograft model.
    Harrington KJ; Rowlinson-Busza G; Uster PS; Vile RG; Peters AM; Stewart JS
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1141-8. PubMed ID: 11240257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
    Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro cytotoxicity, in-vivo biodistribution and anti-tumour effect of PEGylated liposomal topotecan.
    Hao YL; Deng YJ; Chen Y; Wang KZ; Hao AJ; Zhang Y
    J Pharm Pharmacol; 2005 Oct; 57(10):1279-87. PubMed ID: 16259756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes.
    Harrington KJ; Mohammadtaghi S; Uster PS; Glass D; Peters AM; Vile RG; Stewart JS
    Clin Cancer Res; 2001 Feb; 7(2):243-54. PubMed ID: 11234875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
    Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of pegylation and hapten location at the surface of radiolabelled liposomes on tumour immunotargeting using bispecific antibody.
    Rauscher A; Frindel M; Maurel C; Maillasson M; Le Saëc P; Rajerison H; Gestin JF; Barbet J; Faivre-Chauvet A; Mougin-Degraef M
    Nucl Med Biol; 2014 May; 41 Suppl():e66-74. PubMed ID: 24485990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice.
    Schütze C; Bergmann R; Yaromina A; Hessel F; Kotzerke J; Steinbach J; Baumann M; Beuthien-Baumann B
    Radiother Oncol; 2007 Jun; 83(3):311-5. PubMed ID: 17502117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.
    van Schaijk FG; Oosterwijk E; Soede AC; Oyen WJ; McBride WJ; Griffiths GL; Goldenberg DM; Corstens FH; Boerman OC
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3880S-5S. PubMed ID: 14506186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced tumour uptake of radiolabelled antibodies by hyperthermia: Part I: Timing of injection relative to hyperthermia.
    Hauck ML; Zalutsky MR
    Int J Hyperthermia; 2005 Feb; 21(1):1-11. PubMed ID: 15764347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of DTPA entrapped in conventional and long-circulating liposomes of different size for plutonium decorporation.
    Phan G; Herbet A; Cholet S; Benech H; Deverre JR; Fattal E
    J Control Release; 2005 Dec; 110(1):177-88. PubMed ID: 16257469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of IgG in osteosarcoma correlates inversely with interstitial fluid pressure, but not with interstitial constituents.
    de Lange Davies C; Engesaeter BØ; Haug I; Ormberg IW; Halgunset J; Brekken C
    Br J Cancer; 2001 Dec; 85(12):1968-77. PubMed ID: 11747342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the VX2 rabbit auricle carcinoma as a model for head and neck cancer in humans.
    van Es RJ; Dullens HF; van der Bilt A; Koole R; Slootweg PJ
    J Craniomaxillofac Surg; 2000 Oct; 28(5):300-7. PubMed ID: 11467394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tumour size on the in vivo growth inhibition of human colon carcinoma cells (HT-29) by colon mitosis inhibitor.
    Paulsen JE; Elgjo K
    In Vivo; 2001; 15(5):397-401. PubMed ID: 11695236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of irradiation on the biodistribution of radiolabeled pegylated liposomes.
    Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Vile RG; Peters AM; Stewart JS
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):809-20. PubMed ID: 11395251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-12 has no effect on vascular density, perfusion, hypoxia and proliferation of an implanted human squamous cell carcinoma xenograft tumour despite up-regulation of ICAM-1.
    van Herpen CM; Bussink J; van der Kogel AJ; Peeters WJ; van der Voort R; van Schijndel A; de Wilde PC; Adema GJ; de Mulder PH
    Anticancer Res; 2005; 25(2A):1015-21. PubMed ID: 15868941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.